Stock 301520 ANHUI WANBANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Equities

301520

CNE1000068J8

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
44.95 CNY +1.06% Intraday chart for Anhui Wanbang Pharmaceutical Technology Co., Ltd. -4.36% -18.72%
04-19 Anhui Wanbang Pharmaceutical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
2023 Anhui Wanbang Pharmaceutical Technology Co., Ltd. has completed an IPO in the amount of CNY 1.131333 billion. CI

Business Summary

Anhui Wanbang Pharmaceutical Technology Co Ltd is a China-based company primarily engaged in the provision of pharmaceutical research and clinical research services as a comprehensive contract research organization (CRO). The Company mainly provides professional pharmaceutical research and development outsourcing services to pharmaceutical companies and other pharmaceutical research and development institutions. The Company's services mainly include pharmaceutical research services such as generic drug development and consistency evaluation services, as well as clinical research services such as clinical trial operations, clinical trial site management, biological sample analysis, data management and statistical analysis. The Company mainly operates its businesses in the domestic market.

Number of employees: 160

Sales per Business

CNY in Million2022Weight2023Weight Delta
Clinical Research Services
71.3 %
188 72.1 % 244 71.3 % +29.54%
Pharmaceutical Research Services
17.7 %
50 19.2 % 60 17.7 % +20.86%
Other
11.0 %
8 3.1 % 38 11.0 % +366.58%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
261 100.0 % 342 100.0 % +31.07%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 66,666,667 16,500,171 ( 24.75 %) 0 24.75 %

Shareholders

NameEquities%Valuation
Golden Trust Sinopac Fund Management Co., Ltd.
0.1318 %
20,832 0.1318 % 131 899 ¥
Guotai Asset Management Co., Ltd.
0.1044 %
16,500 0.1044 % 104 471 ¥
Penghua Fund Management Co., Ltd.
0.0490 %
7,741 0.0490 % 49 013 ¥
Baoying Fund Management Co., Ltd.
0.0380 %
6,005 0.0380 % 38 021 ¥
Lion Fund Management Co., Ltd.
0.0295 %
4,668 0.0295 % 29 556 ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.0292 %
4,623 0.0292 % 29 271 ¥
HuaAn Fund Management Co., Ltd.
0.0272 %
4,294 0.0272 % 27 188 ¥
China Merchants Fund Management Co., Ltd.
0.0246 %
3,894 0.0246 % 24 655 ¥
Truvalue Asset Management Co. Ltd.
0.0244 %
3,861 0.0244 % 24 446 ¥
Wanjia Asset Management Co., Ltd.
0.0232 %
3,674 0.0232 % 23 262 ¥
NameEquities%Valuation
Chun Lei Tao
51.96 %
26,427,800 51.96 % 167 M ¥
Xin Luo Xu
19.12 %
9,726,200 19.12 % 62 M ¥
Hefei Bairibang Equity Investment Partnership LP
9.164 %
4,661,000 9.164 % 30 M ¥
Ye Yin Qian
3.666 %
1,864,400 3.666 % 12 M ¥
Jiangsu Tianhui Sumintou Industrial Investment Co. Ltd.
3.072 %
1,562,500 3.072 % 10 M ¥
Zibo Zhaofeng Venture Capital Partnership LP
3.055 %
1,553,650 3.055 % 10 M ¥
Ying Shen
2.749 %
1,398,300 2.749 % 9 M ¥
Wenlong Sima
1.833 %
932,200 1.833 % 6 M ¥
HANGZHOU TIGERMED CONSULTING CO., LTD
1.527 %
776,850 1.527 % 5 M ¥
Hefei Hangbang Enterprise Management Partnership LP
1.335 %
678,950 1.335 % 4 M ¥

Company contact information

Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Anhui Wanbang Pharm Bldg 1 Mingzhu Avenue corner Huolongdi Road

230000, Hefei

+

http://www.ahwbyy.cn
address Anhui Wanbang Pharmaceutical Technology Co., Ltd.(301520)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ANHUI WANBANG PHARMACEUTICAL TECHNOLOGY CO., LTD. Stock Anhui Wanbang Pharmaceutical Technology Co., Ltd.
-18.72% 415M
MODERNA, INC. Stock Moderna, Inc.
+33.63% 50.93B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.09% 42.12B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.18% 26.02B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.95% 18.9B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.61% 13.21B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.73% 12.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.31% 12.16B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 301520 Stock
  4. Company Anhui Wanbang Pharmaceutical Technology Co., Ltd.